The PrISICE Clinical Trial (Pre-Implantation Screening and Investigation on the Cryopreservation of Embryos)

NCT03371745 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2022-10-03

No results posted yet for this study

Summary

The trial objective is to determine whether the deferred transfer of embryos following cryopreservation at the blastocyst stage following pre-implantation genetic screening (PGS-FET) improves live birthrates compared to both the deferred transfer of cryopreserved embryos without PGS (FET) and immediate transfer at the conclusion of a "fresh" in vitro fertilization (IVF) cycle (Fresh). Additionally, whether "freeze-only" (FET) improves live birth rates compared to "fresh" will be determined.

Conditions

Interventions

PROCEDURE

Trophectoderm biopsy

Biopsy at blastocyst stage of trophectoderm cells for comprehensive evaluation of the eupolid status of the embryo.

PROCEDURE

Cryopreservation

Rapid freezing using vitrification

PROCEDURE

Embryo Transfer

Transfer of embryo that has been cultured in vitro into the uterus

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • University of California, San Francisco

    collaborator OTHER
  • University of Pennsylvania

    collaborator OTHER
  • Augusta University

    collaborator OTHER
  • Penn State University

    collaborator OTHER
  • University of North Carolina

    collaborator OTHER
  • University of Oklahoma

    collaborator OTHER
  • Yale University

    lead OTHER

Principal Investigators

  • Esther Eisenberg, MD · Eunice Kennedy Shriver National Institue of Child Health and Human Development

  • Nanette Santoro, MD · University of Colorado, Denver

  • Marcelle I Cedars, MD · University of California, San Francisco

  • Christos Coutifaris, MD PhD · University of Pennsylvania

  • Heping Zhang, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-21
Primary Completion
2019-10-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03371745 on ClinicalTrials.gov